Abstract
Background
Vitamin D deficiency (VDD) is seen in all races, age groups, and ethnic backgrounds. VDD estimated to affect >1 billion people worldwide. The purpose of the present study is to characterize the extent of Vitamin D inadequacy and parathyroid hormone (PTH) levels among patients presenting to us for fracture management.
Materials and Methods
A prospective case-control study was performed whereby serum Vitamin D levels and corresponding PTH levels were measured. The study subjects included patients >45 years of age irrespective of sex who presented with fracture as a result of trivial trauma. A total of 102 cases (34 intertrochanteric fracture, 66 fracture neck of femur, and 2 Colle’s fracture) and 100 controls were included in the study.
Result
Average serum hydroxy-vitamin D and serum PTH of cases 15.8 ± 5.25 ng/mL and 91.15 ± 6.03 pg/mL, respectively. Average S.25-OH Vitamin D and serum PTH of controls was 25.49 ± 3.79 ng/mL and 23.46 ± 3.79 pg/mL, respectively. Eighty (78.4%) cases were in insufficient range (Vitamin D between 10–30 ng/mL), 16 (15.6%) were deficient (Vitamin D <10 ng/mL), and only 6 (5.8%) were sufficient (Vitamin D >30 ng/mL). While in controls, 28% had sufficient and 72% had insufficient Vitamin D levels. There was no deficient control. Serum PTH levels were significantly raised in cases when compared to controls consistent with secondary hyperparathyroidism.
Conclusion
This study gives us very important data regarding the prevalence of VDD and rise of PTH secondary to the former and this hormonal milieu in our body is an independent risk factor for increased incidence of fracture.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–81.
Ahmed W, Khan N, Glueck CJ, Pandey S, Wang P, Goldenberg N, et al. Low serum 25 (OH) Vitamin D levels (< 32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 2009;153:11–6.
Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int 2002;13:187–94.
Glerup H, Eriksen EF. Acroparaesthesia – A typical finding in Vitamin D deficiency. Rheumatology (Oxford) 1999;38:482.
Schott GD, Wills MR. Muscle weakness in osteomalacia. Lancet 1976;1:626–9.
Skaria J, Katiyar BC, Srivastava TP, Dube B. Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 1975;51:37–58.
Malhotra N, Mithal A. Osteoporosis in Indians. Indian J Med Res 2008;127:263–8.
Khadgawat R, Brar KS, Gahlo M, Yadav CS, Malhotra R, Guptat N, et al. High prevalence of Vitamin D deficiency in Asian-Indian patients with fragility hip fracture: A pilot study. J Assoc Physicians India 2010;58:539–42.
Rao DS, Agarwal G, Talpos GB, Phillips ER, Bandeira F, Mishra SK, et al. Role of Vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: A global perspective. J Bone Miner Res 2002;17 Suppl 2:N75–80.
LeBoff MS, Hawkes WG, Glowacki J, Yu-Yahiro J, Hurwitz S, Magaziner J, et al. Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int 2008;19:1283–90.
Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 2000;66:419–24.
Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose Vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: A randomized controlled trial. Cerebrovasc Dis 2005;20:187–92.
Moreira-Pfrimer LD, Pedrosa MA, Teixeira L, Lazaretti-Castro M. Treatment of Vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: A randomized double-blind controlled trial. Ann Nutr Metab 2009;54:291–300.
Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C, et al. Effects of a short-term Vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000;15:1113–8.
Dhesi JK, Jackson SH, Bearne LM, Moniz C, Hurley MV, Swift CG, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 2004;33:589–95.
Bunout D, Barrera G, Leiva L, Gattas V, de la Maza MP, Avendaño M, et al. Effects of Vitamin D supplementation and exercise training on physical performance in Chilean Vitamin D deficient elderly subjects. Exp Gerontol 2006;41:746–52.
Marcinkowska E. A run for a membrane Vitamin D receptor. Biol Signals Recept 2001;10:341–9.
Bellido T, Boland R. Effects of 1,25-dihydroxy-Vitamin D3 on phosphate accumulation by myoblasts. Horm Metab Res 1991;23:113–6.
Rodman JS, Baker T. Changes in the kinetics of muscle contraction in Vitamin D-depleted rats. Kidney Int 1978;13:189–93.
LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J, et al. Occult Vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999;281:1505–11.
Johnell O, Gullberg B, Kanis JA, Allander E, Elffors L, Dequeker J, et al. Risk factors for hip fracture in European women: The MEDOS study. Mediterranean osteoporosis study. J Bone Miner Res 1995;10:1802–15.
Lau EM, Suriwongpaisal P, Lee JK, Das De S, Festin MR, Saw SM, et al. Risk factors for hip fracture in Asian men and women: The Asian osteoporosis study. J Bone Miner Res 2001;16:572–80.
Fujiwara S. Epidemiology of osteoporosis in Japan. J Bone Miner Metab 2005;23 Suppl: 81–3.
Harinarayan CV, Joshi SR. Vitamin D status in India – Its implications and remedial measures. J Assoc Physicians India 2009;57:40–8.
Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between Vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab 2011;96:E436–46.
Kim G, Oh KW, Jang EH, Kim MK, Lim DJ, Kwon HS, et al. Relationship between Vitamin D, parathyroid hormone, and bone mineral density in elderly Koreans. J Korean Med Sci 2012;27:636–43.
Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL, et al. Evidence of an age-related decrease in intestinal responsiveness to Vitamin D: Relationship between serum 1,25-dihydroxyvitamin D3 and intestinal Vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 1992;75:176–82.
Pattanaungkul S, Riggs BL, Yergey AL, Vieira NE, O’Fallon WM, Khosla S, et al. Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH) 2D] levels in young versus elderly women: Evidence for age-related intestinal resistance to 1,25(OH) 2D action. J Clin Endocrinol Metab 2000;85:4023–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shaan, Z.H., Ahmad, S., Jilani, L.Z. et al. Status of Vitamin D and Parathyroid Hormone in Patients Scheduled to Undergo Orthopedic Fracture Management: A Case-Control Study. JOIO 53, 183–189 (2019). https://doi.org/10.4103/ortho.IJOrtho_25_17
Published:
Issue Date:
DOI: https://doi.org/10.4103/ortho.IJOrtho_25_17